Understanding Your Laboratory Test: Purpose, Procedure, and Results
This test measures the amount of 3,4-dihydroxyphenylacetate (DHPAA) in your urine, a substance that can indicate certain medical conditions.
{"DHPAA is a breakdown product of dopamine, a brain chemical","The test helps screen for neuroblastoma, a type of childhood cancer","It may also help monitor certain neurological conditions","A simple urine sample is all that's needed","Results help doctors determine if additional testing is necessary"}
Key facts at a glance
- LOINC
- 108555-4
- Short code
- DHPPAU
- Synonyms
- 3,4-DiOH-phenylacetate Msmt Ur
- Category
- chemistry
- Sample
- urine
- Container
- Sterile plastic urine container (24-hour collection requires preserved container with appropriate preservative)
- Units
- N/A
- Ref low
- 1
- Ref high
- 7
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- High Performance Liquid Chromatography (HPLC) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
- CPT
- 82128
- SNOMED
- 314255006
- Specimen volume
- 10-50 mL for spot urine; complete 24-hour collection volume for timed specimens
- Stability
- Refrigerate at 2-8°C during collection. Stable for up to 7 days refrigerated. For longer storage, freeze at -20°C or below.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 48–168 hours
- Order
- routine
This is a laboratory test that helps your healthcare provider evaluate important markers in your body, often from a blood, urine, or other sample, to check how well your organs are working and to look for signs of possible health conditions.
The 3,4-dihydroxyphenylacetate (DHPAA) test measures how much of this substance is in your urine. DHPAA is a byproduct formed when your body breaks down dopamine, a important chemical messenger in the brain and nervous system.
Your provider may order this test as part of a routine checkup, to help find the cause of symptoms you are having, to monitor a condition you already know about, or to see how well a treatment you are receiving is working over time.
Doctors may order this test to help: 1) Screen for neuroblastoma, a rare cancer that most often affects children under 5 years old; 2) Monitor people with certain nervous system disorders; or 3) Check how well treatment is working for conditions that affect dopamine levels.
The test usually involves collecting a small sample, most often blood drawn from a vein in your arm with a thin needle, though some tests use urine, saliva, or a simple swab. The sample is then sent to a laboratory and analyzed by trained professionals.
This is a simple urine test. You will be asked to provide a urine sample in a sterile container. The sample is then sent to a laboratory where technicians measure the amount of DHPAA. No fasting or special preparation is typically required.
Your results are compared with standard reference ranges. Values within the expected range generally suggest normal findings, while values that are too high or too low may point to a condition that needs closer attention. Your provider will explain what your specific numbers mean for you.
Normal results vary by age and laboratory. Higher than normal levels of DHPAA in urine may indicate: neuroblastoma, certain brain disorders, or conditions that affect dopamine metabolism. Your doctor will interpret your results based on your age, symptoms, and other test results.
The risks are usually very small. You may feel a brief sting when the needle is inserted, and you might have mild soreness or a small bruise at the site afterward. Serious problems such as infection or excessive bleeding are rare. Tell your provider if you take blood thinners or have a bleeding disorder.
This is a safe test with no significant risks. The main discomfort is minor - giving a urine sample. Some people may find it slightly uncomfortable to urinate into a container.
Reference range
Reference range: 1.0-7.0 mg/24h (varies by laboratory method and population)N/A
No special preparation required. Collect urine as instructed by healthcare provider. Inform about any medications or supplements being taken as they may affect results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Elevated urinary DHPAA is primarily used as a tumor marker for neuroblastoma, a cancer that develops from immature nerve cells (neuroblasts). It may also be elevated in pheochromocytoma and certain neurological disorders. The test is often used alongside other catecholamine metabolite tests (like HVA and VMA) for more accurate diagnosis. Monitoring DHPAA levels can also help track treatment response in patients with these conditions.
Frequently asked questions
Do I need to fast before this test?
How long does it take to get results?
Is this test only for children?
What happens if my results are abnormal?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy